News
-
-
-
COMMUNIQUÉ DE PRESSE
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
Onco-Innovations Limited's subsidiary, Inka Health Corp., selected by OneMedNet Corporation for data analytics initiative to improve cancer therapy processes and accelerate market entry for new therapies -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 243,903 units at $1.64 per unit for proceeds of $400,000. Additionally, incentive stock options and restricted share units are granted. Company focuses on cancer research and treatment -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
Onco-Innovations Limited appoints Dr. Dennis Hall, renowned chemist, to Scientific and Clinical Advisory Board. Dr. Hall brings expertise in boron chemistry, catalysis, and drug discovery to advance innovative oncology-focused therapies -